We are live on ! Find out more
CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
PAI
1
Palo Alto Investors
California
$124M +$28.3M +438,911 +14%
PC
2
PointState Capital
New York
$123M +$223M +3,453,900 +6,908%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$95.5M -$45.6M -707,365 -21%
Vanguard Group
4
Vanguard Group
Pennsylvania
$78.2M +$10.9M +169,332 +8%
PHS
5
PFM Health Sciences
California
$72.7M -$30.6M -474,447 -19%
Goldman Sachs
6
Goldman Sachs
New York
$65.4M +$115M +1,783,802 +2,090%
RG
7
Redmile Group
California
$62.9M +$54.1M +838,302 +88%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$55.4M -$22.8M -353,978 -18%
HM
9
HealthCor Management
New York
$53.4M +$98.3M +1,525,000 New
State Street
10
State Street
Massachusetts
$51.9M +$48.5M +752,552 +103%
AA
11
Antipodean Advisors
New York
$44.4M -$2.44M -37,833 -3%
O
12
OppenheimerFunds
New York
$43.6M -$6.6M -102,300 -8%
Millennium Management
13
Millennium Management
New York
$41.1M +$56.5M +876,068 +294%
BFA
14
BlackRock Fund Advisors
California
$40.4M -$5.28M -81,894 -7%
NMC
15
NEA Management Company
Maryland
$39.9M
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$33M +$38.5M +596,215 +172%
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$30.1M +$24.3M +376,923 +78%
BIT
18
BlackRock Institutional Trust
California
$27M +$905K +14,029 +2%
O
19
OrbiMed
New York
$25.5M -$24.3M -376,300 -34%
CPCM
20
Clifton Park Capital Management
Delaware
$21.4M -$17.4M -270,391 -31%
LPU
21
Lansdowne Partners (UK)
United Kingdom
$19.6M +$36.1M +559,534 New
VAM
22
Visium Asset Management
New York
$18.8M -$15.8M -244,811 -31%
BB
23
BB Biotech
Switzerland
$18.5M -$5.8M -90,000 -15%
VVM
24
Versant Venture Management
California
$14.3M
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$12.9M +$23.1M +358,600 +3,270%